Devro (LON:DVO) announced its earnings results on Tuesday. The company reported GBX 12.50 ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of GBX 13.80 ($0.19) by GBX (1.30) (($0.02)), Bloomberg Earnings reports. The business had revenue of £2,569 billion for the quarter. Devro had a net margin of 7.43% and a return on equity of 16.21%.
Devro (LON DVO) traded up GBX 2 ($0.03) during trading on Thursday, reaching GBX 198.80 ($2.75). 311,629 shares of the company were exchanged, compared to its average volume of 104,908. Devro has a 12 month low of GBX 175 ($2.42) and a 12 month high of GBX 247 ($3.41). The stock has a market cap of $333.90 and a price-to-earnings ratio of 2,208.89.
In other news, insider Rutger Helbing acquired 2,000 shares of Devro stock in a transaction that occurred on Monday, December 11th. The shares were bought at an average cost of GBX 226 ($3.12) per share, with a total value of £4,520 ($6,244.82). Also, insider Gerard Hoetmer acquired 25,000 shares of Devro stock in a transaction that occurred on Tuesday, February 27th. The stock was purchased at an average cost of GBX 200 ($2.76) per share, for a total transaction of £50,000 ($69,079.86).
Devro Company Profile
Devro plc is a United Kingdom-based manufacturer of collagen products for the food industry. The Company conducts its operations through three segments: Americas, Asia-Pacific and Europe. The Americas segment includes the Company’s operations in North America and Latin America. The Asia-Pacific segment includes the Company’s operations in Australia, New Zealand, Japan, China and the rest of South East Asia.
Receive News & Ratings for Devro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Devro and related companies with MarketBeat.com's FREE daily email newsletter.